Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.1016/J.BIOORG.2014.03.007 | ||||
| Año | 2014 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
Proteins involved in bacterial cell division often do not have a counterpart in eukaryotic cells and they are essential for the survival of the bacteria. The genetic accessibility of many bacterial species in combination with the Green Fluorescence Protein revolution to study localization of proteins and the availability of crystal structures has increased our knowledge on bacterial cell division considerably in this century. Consequently, bacterial cell division proteins are more and more recognized as potential new antibiotic targets. An international effort to find small molecules that inhibit the cell division initiating protein FtsZ has yielded many compounds of which some are promising as leads for preclinical use. The essential transglycosylase activity of peptidoglycan synthases has recently become accessible to inhibitor screening. Enzymatic assays for and structural information on essential integral membrane proteins such as MraY and FtsW involved in lipid II (the peptidoglycan building block precursor) biosynthesis have put these proteins on the list of potential new targets. This review summarises and discusses the results and approaches to the development of lead compounds that inhibit bacterial cell division. (C) 2014 Elsevier Inc. All rights reserved.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | den Blaauwen, Tanneke | Mujer |
Univ Amsterdam - Países Bajos
Swammerdam Institute for Life Sciences - Países Bajos |
| 2 | Andreu, Jose M. | Hombre |
CSIC - España
CSIC - Centro de Investigaciones Biologicas (CIB) - España CSIC - Centro de Investigaciones Biológicas Margarita Salas (CIB) - España |
| 3 | MONASTERIO-OPAZO, OCTAVIO HERNAN | Hombre |
Universidad de Chile - Chile
|
| Fuente |
|---|
| FONDECYT |
| MINECO |
| Ministerio de Economía y Competitividad |
| Fondo Nacional de Desarrollo Científico y Tecnológico |
| European Commission |
| Ministerio de EconomÃa y Competitividad |
| Fondo Nacional de Desarrollo CientÃfico, Tecnológico y de Innovación Tecnológica |
| DIVINOCELL project of the European Commission |
| Agradecimiento |
|---|
| We would like to thank Professors Chi-Huey Wong and Che Ma the Genomics Research Center, Academia Sinica, Taipei 115, Taiwan and the Institutes of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan for the gift of Fig. 2 from their publication [12] and Prof. Jared Shaw for critically reading the manuscript. O.M. and T.d.B. were supported by the DIVINOCELL project of the European Commission (FP7-Health-2007-B-223431), O.M. by FONDECYT # 1130711 and J.M.A. by MINECO BFU2011-23416. |
| We would like to thank Professors Chi-Huey Wong and Che Ma the Genomics Research Center, Academia Sinica, Taipei 115, Taiwan and the Institutes of Microbiology and Immunology, National Yang-Ming University, Taipei 112, Taiwan for the gift of Fig. 2 from their publication [12] and Prof. Jared Shaw for critically reading the manuscript. O.M. and T.d.B. were supported by the DIVINOCELL project of the European Commission (FP7-Health-2007-B-223431), O.M. by FONDECYT # 1130711 and J.M.A. by MINECO BFU2011-23416. |